Ashland is a global specialty materials company headquartered in Wilmington, Delaware, USA, and listed on the New York Stock Exchange (ASH). The company develops and manufactures specialty additives and ingredients serving life sciences, personal care, coatings, construction, and other industrial markets.
Its portfolio includes cellulose ethers and other water‑soluble polymers, vinyl pyrrolidone–based polymers (such as PVP and crospovidone), bioresorbable polymers for drug delivery and medical devices, and a broad range of rheology modifiers, dispersants, surfactants, defoamers, and film formers used in paints, adhesives, sealants, and specialty formulations. In pharmaceuticals, Ashland supplies GMP‑grade excipients and formulation solutions; in personal care, it provides ingredients for skin, hair, and oral care; and in coatings and construction, it offers additives that enhance flow, stability, and durability.
Ashland operates R&D and manufacturing facilities across North America, Europe, and Asia and supports customers with technical and regulatory expertise worldwide.
